Share on StockTwits

Baxano Surgical (NASDAQ:BAXS) CEO Kenneth Michael Reali purchased 10,000 shares of the company’s stock on the open market in a transaction that occurred on Friday, August 15th. The shares were purchased at an average cost of $0.38 per share, for a total transaction of $3,800.00. Following the completion of the transaction, the chief executive officer now directly owns 141,128 shares of the company’s stock, valued at approximately $53,629. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Baxano Surgical (NASDAQ:BAXS) traded up 5.77% during mid-day trading on Tuesday, hitting $0.3903. The stock had a trading volume of 309,695 shares. Baxano Surgical has a 52 week low of $0.36 and a 52 week high of $1.99. The stock’s 50-day moving average is $0.50 and its 200-day moving average is $0.86. The company’s market cap is $18.9 million.

Baxano Surgical (NASDAQ:BAXS) last posted its quarterly earnings results on Tuesday, August 5th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by $0.04. On average, analysts predict that Baxano Surgical will post $-0.58 earnings per share for the current fiscal year.

Baxano Surgical Inc, formerly TranS1 Inc, is a medical device company focused on designing, developing and marketing products that implement its approach to treat degenerative conditions of the spine affecting the lower lumbar region.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.